Skip to main content
. 2021 Jan 6;5(1):e20636. doi: 10.2196/20636

Table 1.

Demographic and treatment characteristics of the patients in this study (N=9).

Characteristic Value
Gender, n (%)
Men 6 (67)
Women 3 (33)
Age (years), n (%)
40-49 2 (22)
50-59 4 (44)
60-69 2 (22)
70-79 1 (11)
Oncology treatment plan, n (%)
Chemoradiotherapy (radiation plus concomitant capecitabine) 6 (67)
Intravenous chemotherapy every 3rd week plus capecitabine 3 (33)
Smartphone system, n (%)
IOS (iPhone) 6 (67)
Android (Samsung) 3 (33)
Level of education
College/university 7 (78)
High school 2 (22)